Glucose Health, Inc. is an under-the-radar company whose GLUCODOWN® products are found in major national pharmacy chains including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and even online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $20 million valuation.
Glucose Health, Inc. (GLUC) Unveils GLUCODOWN® "Enhanced Water" Drink Mix Retail Packaging and 2020 Launch Date
Joe Biden wants to put the U.S. on track to achieve "a 100% clean energy economy and Brookfield Renewable Partners (NYSE:BEP) stands out as one stock positioned to perform especially well as three-quarters of the company's funds from operations (FFO) comes from its hydroelectric facilities.
Take a look at Glucose Health, Inc. (OTC Pink: GLUC). Trading with less than a $20 million valuation, Glucose Health manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®.
The Best Healthcare Stocks for 2020. Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.
On the healthcare front, Edesa Biotech (NASDAQ: EDSA) has an interesting chart. Between $8 and 9.00 per share sits a major pivot created on August 11, 2020. If the stock can maintain above it, the ceiling will become the floor and the stock will have room to $19.00 per share.
This is a play on the treatment of Covid-19 rather than a preventative vaccine Before the pandemic, one of the flagship drugs under the Can-Fite pipeline was Piclidenoson. An orally administered drug, Piclidenoson is essentially a small-molecule inhibitor that targets enzymes that cause inflammation.
Glucose Health (GLUC) Expanded Inventory to Meet Consumer Demand Plus all New GLUCODOWN® "Enhanced Water" Beverages From Glucose Health, Inc.